Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity (Deficit)

v3.23.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Total
IPO
Common Stock
Common Stock
IPO
Additional Paid-In Capital
Additional Paid-In Capital
IPO
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ 9,784,356   $ 10,051   $ 24,805,929     $ (15,031,624)
Beginning balance, Shares at Dec. 31, 2020     10,050,849          
Stock-based compensation expense 1,531,876       1,531,876      
Issuance of warrants 688,784       688,784      
Issuance of common stock 60,391 $ 41,135,357 $ 9 $ 15,000 60,382 $ 41,120,357    
Issuance of common stock, Shares     9,000 15,000,000        
Conversion of notes 848   $ 95   753      
Conversion of notes, Shares     95,349          
Net loss (14,786,063)             (14,786,063)
Ending balance at Dec. 31, 2021 $ 38,415,549   $ 25,155   68,208,081     (29,817,687)
Ending balance, Shares at Dec. 31, 2021 25,155,198   25,155,198          
Stock-based compensation expense $ 458,147       458,147      
Issuance of warrants 0              
Issuance of common stock 67,000   $ 50   66,950      
Issuance of common stock, Shares     50,000          
Stock Issued During Period, Value, Stock Options Exercised 44,142   $ 22   44,120      
Issuance of common stock, stock options exercised, Shares     21,853          
Other comprehensive income 104,718           $ 104,718  
Net loss (18,054,155)             (18,054,155)
Ending balance at Dec. 31, 2022 $ 21,035,401   $ 25,227   $ 68,777,298   $ 104,718 $ (47,871,842)
Ending balance, Shares at Dec. 31, 2022 25,227,051   25,227,051